Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dobrin Vassilev

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 26, 2018
Complex coronary bifurcation treatment by a novel stenting technique: Bench test, fluid dynamic study and clinical outcomesGianluca Rigatelli, Marco Zuin, Fabio Dell'Avvocata, et al.
The Canadian Journal of Cardiology|April 2, 2015
Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I TrialRobert J Gil, Jacek Bil, Vladimír Džavík, et al.
The International Journal of Cardiovascular Imaging|November 17, 2020
Feasibility, safety and long-term outcomes of complex left main bifurcation treatment using the nano-inverted-t stenting: a multicentre prospective registryGianluca Rigatelli, Marco Zuin, Dobrin Vassilev, et al.
Cardiology Journal|August 26, 2017
Comparison of dedicated BIOSS bifurcation stents with regular drug-eluting stents for coronary artery bifurcated lesions: Pooled analysis from two randomized studiesRobert J Gil, Jacek Bil, Adam Kern, et al.
Cardiovascular Therapeutics|May 16, 2020
Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II StudiesRobert J Gil, Jacek Bil, Adam Kern, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2018
Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trialsRobert J Gil, Jacek Bil, Adam Kern, et al.
The International Journal of Cardiovascular Imaging|November 18, 2018
Culotte versus the novel nano-crush technique for unprotected complex bifurcation left main stenting: difference in procedural time, contrast volume and X-ray exposure and 3-years outcomesGianluca Rigatelli, Marco Zuin, Dobrin Vassilev, et al.
Kardiologia Polska|April 23, 2021
Left ventricle non-compaction with a dilative phenotype and novel genetic mutationsMonika Shumkova, Dobrin Vassilev, Kiril Karamfiloff, et al.
The American Journal of Cardiology|April 13, 2020
Risk of Dislodgement of Ultrathin Drug Eluting Stents Versus Thick Drug Eluting StentsGianluca Rigatelli, Marco Zuin, Dobrin Vassilev, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 26, 2012
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers populationRobert J Gil, Dobrin Vassilev, Aleksandra Michalek, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 26, 2018
Complex coronary bifurcation treatment by a novel stenting technique: Bench test, fluid dynamic study and clinical outcomesGianluca Rigatelli, Marco Zuin, Fabio Dell'Avvocata, et al.
The Canadian Journal of Cardiology|April 2, 2015
Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I TrialRobert J Gil, Jacek Bil, Vladimír Džavík, et al.
The International Journal of Cardiovascular Imaging|November 17, 2020
Feasibility, safety and long-term outcomes of complex left main bifurcation treatment using the nano-inverted-t stenting: a multicentre prospective registryGianluca Rigatelli, Marco Zuin, Dobrin Vassilev, et al.
Cardiology Journal|August 26, 2017
Comparison of dedicated BIOSS bifurcation stents with regular drug-eluting stents for coronary artery bifurcated lesions: Pooled analysis from two randomized studiesRobert J Gil, Jacek Bil, Adam Kern, et al.
Cardiovascular Therapeutics|May 16, 2020
Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II StudiesRobert J Gil, Jacek Bil, Adam Kern, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2018
Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trialsRobert J Gil, Jacek Bil, Adam Kern, et al.
The International Journal of Cardiovascular Imaging|November 18, 2018
Culotte versus the novel nano-crush technique for unprotected complex bifurcation left main stenting: difference in procedural time, contrast volume and X-ray exposure and 3-years outcomesGianluca Rigatelli, Marco Zuin, Dobrin Vassilev, et al.
Kardiologia Polska|April 23, 2021
Left ventricle non-compaction with a dilative phenotype and novel genetic mutationsMonika Shumkova, Dobrin Vassilev, Kiril Karamfiloff, et al.
The American Journal of Cardiology|April 13, 2020
Risk of Dislodgement of Ultrathin Drug Eluting Stents Versus Thick Drug Eluting StentsGianluca Rigatelli, Marco Zuin, Dobrin Vassilev, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 26, 2012
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers populationRobert J Gil, Dobrin Vassilev, Aleksandra Michalek, et al.
Pageof 9